G. Quinnan,

发表

Potential for single high-dose influenza immunization in unprimed children.

C. Denning, P. Gross, P. Gaerlan, 1982, Pediatrics.

Association of influenza immunization with reduction in mortality in an elderly population. A prospective study.

S. Wallenstein, R. Kaslow, A. Saah, 1988, Archives of internal medicine.

Mutagenesis of CXCR4 Identifies Important Domains for Human Immunodeficiency Virus Type 1 X4 Isolate Envelope-Mediated Membrane Fusion and Virus Entry and Reveals Cryptic Coreceptor Activity for R5 Isolates

C. Broder, Peng-fei Zhang, Donald J. Chabot, 1999, Journal of Virology.

Comparative virulence and immunogenicity of the Towne strain and a nonattenuated strain of cytomegalovirus.

S. Plotkin, J. Manischewitz, J. Epstein, 1984, Annals of internal medicine.

Potent and broad neutralizing activity of a single chain antibody fragment against cell-free and cell-associated HIV-1

R. Ptak, B. Haynes, D. Dimitrov, 2010, mAbs.

Humoral Antibody Responses to HIV Viral Proteins and to CD4 Among HIV Controllers, Rapid and Typical Progressors in an HIV-Positive Patient Cohort

B. Agan, A. Saphire, E. Berger, 2016, AIDS research and human retroviruses.

Comparative inhibition of chloramphenicol acetyltransferase gene expression by antisense oligonucleotide analogues having alkyl phosphotriester, methylphosphonate and phosphorothioate linkages.

G. Zon, K. Shinozuka, G. Quinnan,, 1987, Nucleic acids research.

Immunization of elderly people with two doses of influenza vaccine

R. Douglas, C. Denning, P. Gross, 1987, Journal of clinical microbiology.

Induction of neutralizing antibodies to Hendra and Nipah glycoproteins using a Venezuelan equine encephalitis virus in vivo expression system.

C. Broder, G. Quinnan,, G. Defang, 2010, Vaccine.

High prevalence of antibodies to the gp120 V3 region principal neutralizing determinant of HIV-1MN in sera from Africa and the Americas.

R. M. Hendry, S. Rastogi, G. Quinnan,, 1991, AIDS research and human retroviruses.

Intestinal infections in patients with the acquired immunodeficiency syndrome (AIDS). Etiology and response to therapy.

A. Fauci, H. Masur, H. Lane, 1988, Annals of internal medicine.

Inactivation and partition of human T‐cell lymphotrophic virus, type III, during ethanol fractionation of plasma

J. Epstein, A. Wittek, G. Quinnan,, 1986, Transfusion.

Potential use of new poliomyelitis vaccines: memorandum from a WHO meeting.

V. Agol, S. Lemon, D. Henderson, 1990, Bulletin of the World Health Organization.

Epstein-Barr virus in the bone marrow of patients with aplastic anemia.

N. Young, S. Straus, G. Quinnan,, 1988, Annals of internal medicine.

Expression and characterization of HIV type 1 envelope protein associated with a broadly reactive neutralizing antibody response.

H. Alter, G. Quinnan,, P. Zhang, 1999, AIDS research and human retroviruses.

Clofazimine for Treatment of Cryptosporidiosis in Human Immunodeficiency Virus Infected Adults: An Experimental Medicine, Randomized, Double-blind, Placebo-controlled Phase 2a Trial

L. Sawyer, D. Operario, R. Lindblad, 2020, Clinical Infectious Diseases.

Evaluating the safety, tolerability, pharmacokinetics and efficacy of clofazimine in cryptosporidiosis (CRYPTOFAZ): study protocol for a randomized controlled trial

W. V. Van Voorhis, M. Gordon, D. Hermann, 2018, Trials.

The role of specific IgE and beta-propiolactone in reactions resulting from booster doses of human diploid cell rabies vaccine.

D. Frazier, G. Quinnan,, H. Baer, 1987, The Journal of allergy and clinical immunology.

Use of a sensitive neutralization assay to measure the prevalence of antibodies to the human immunodeficiency virus.

R. M. Hendry, D. Shepp, A. Wittek, 1988, The Journal of infectious diseases.

Varicella-zoster virus-specific HLA-restricted cytotoxicity of normal immune adult lymphocytes after in vitro stimulation.

G. Quinnan,, L. Vujcic, E. C. Cooper, 1988, The Journal of infectious diseases.

Annual influenza vaccination: immune response in patients over 10 years.

S. Wallenstein, C. Denning, P. Gross, 1996, Vaccine.

Association of influenza immunization with reduction in mortality in an elderly population. A prospective study

P. Gross, G. Quinnan,, M. Rodstein, 1990 .

Epidemiology of acute respiratory illness during an influenza outbreak in a nursing home. A prospective study.

S. Wallenstein, R. Kaslow, A. Saah, 1988, Archives of internal medicine.

Comparison of live and inactivated influenza vaccine in high risk children.

P. Wright, C. Denning, P. Gross, 1987, Vaccine.

Immunization of Elderly People with High Doses of Influenza Vaccine

C. Denning, P. Gross, M. Weksler, 1988, Journal of the American Geriatrics Society.

Quantitation of poliovirus antigens in inactivated viral vaccines by enzyme-linked immunosorbent assay using animal sera and monoclonal antibodies.

G. Quinnan,, F. Knauert, R. Lundquist, 1989, Journal of biological standardization.

Large granular lymphocytes provide an accessory function in the in vitro development of influenza A virus-specific cytotoxic T cells.

S. Kiley, J. Djeu, G. Quinnan,, 1984, Journal of immunology.

Involvement of natural killer cells in the pathogenesis of murine cytomegalovirus interstitial pneumonitis and the immune response to infection.

J. Manischewitz, G. Quinnan,, N. Kirmani, 1982, The Journal of general virology.

Antivirus antibody-dependent cell-mediated cytotoxicity during murine cytomegalovirus infection

G. Quinnan,, J. Manischewitz, 1980, Infection and immunity.

Cytotoxic T lymphocyte response to murine cytomegalovirus infection

F. Ennis, G. Quinnan,, J. Manischewitz, 1978, Nature.

Cell-Mediated Immunity in Cytomegalovirus Infections

G. Quinnan,, 1985 .

Latent cytomegalovirus infection of BALB/c mouse spleens detected by an explant culture technique.

F. Ennis, G. Quinnan,, T. Wise, 1979, The Journal of general virology.

Mechanisms of T-cell functional deficiency in the acquired immunodeficiency syndrome.

J. Manischewitz, J. Epstein, J. Siegel, 1985, Annals of internal medicine.

HLA-restricted cytotoxic T lymphocyte and nonthymic cytotoxic lymphocyte responses to cytomegalovirus infection of bone marrow transplant recipients.

J. Manischewitz, A. Rook, G. Quinnan,, 1981, Journal of immunology.

Cytotoxic antibodies to natural killer cells in systemic lupus erythematosus.

G. Tsokos, J. Djeu, J. Balow, 1982, Clinical immunology and immunopathology.

Invasive activity and chemotactic response to growth factors by Kaposi's sarcoma cells

G. Martin, E. Thompson, A. Wittek, 1988, Journal of cellular biochemistry.

Interleukin-2 enhances the depressed natural killer and cytomegalovirus-specific cytotoxic activities of lymphocytes from patients with the acquired immune deficiency syndrome.

A. Fauci, H. Masur, H. Lane, 1983, The Journal of clinical investigation.

Use of interleukin-2 in patients with acquired immunodeficiency syndrome.

E. Gelmann, A. Fauci, H. Masur, 1984, Journal of biological response modifiers.

Cytomegalovirus-specific cytotoxicity mediated by non-T lymphocytes from peripheral blood of normal volunteers

J. Manischewitz, G. Quinnan,, K. Mittal, 1981, Infection and immunity.

Cytotoxic lymphocytes and antibody-dependent complement-mediated cytotoxicity induced by administration of influenza vaccine

R. Armstrong, F. Ennis, G. Butchko, 1980, Infection and immunity.

Serologic responses and systemic reactions in adults after vaccination with monovalent A/USSR/77 and trivalent A/USSR/77, A/Texas/77, B/Hong Kong/72 influenza vaccines.

R. Schooley, F. Ennis, P. Gross, 1983, Reviews of infectious diseases.

Induction, persistence and strain specificity of haemagglutinin-specific secretory antibodies in lungs of mice after intragastric administration of inactivated influenza virus vaccines.

G. Quinnan,, K. S. Chen, K. S. Chen, 1988, The Journal of general virology.

ROLE OF INTERFERON IN AIDS a

E. Gelmann, R. Friedman, J. Vilček, 1984, Annals of the New York Academy of Sciences.

Secretory immunoglobulin A antibody response is conserved in aged mice following oral immunization with influenza virus vaccine.

G. Quinnan,, K. S. Chen, K. S. Chen, 1989, The Journal of general virology.

Herpesvirus infections in the acquired immune deficiency syndrome.

H. Masur, J. Parrillo, M. Parker, 1984, JAMA.

Importance of Cytotoxic Lymphocytes During Cytomegalovirus Infection in Renal Transplant Recipients

J. Manischewitz, A. Rook, G. Quinnan,, 1984 .

Mutations in both gp120 and gp41 Are Responsible for the Broad Neutralization Resistance of Variant Human Immunodeficiency Virus Type 1 MN to Antibodies Directed at V3 and Non-V3 Epitopes

G. Quinnan,, Gerald V. Quinnan, Eun Ju Park, 1998, Journal of Virology.

Evolution of neutralizing antibody response against HIV type 1 virions and pseudovirions in multicenter AIDS cohort study participants.

J. Margolick, G. Quinnan,, P. F. Zhang, 1998, AIDS research and human retroviruses.

Death in the AIDS patient: role of cytomegalovirus.

D. Longo, A. Fauci, H. Lane, 1983, The New England journal of medicine.

Active synthesis of hemagglutinin-specific immunoglobulin A by lung cells of mice that were immunized intragastrically with inactivated influenza virus vaccine

G. Quinnan,, D. Burlington, K. Chen, 1987, Journal of virology.

Synergistic effect of ganciclovir and foscarnet on cytomegalovirus replication in vitro

J. Manischewitz, A. Wittek, G. Quinnan,, 1990, Antimicrobial Agents and Chemotherapy.

Importance of cytotoxic lymphocytes during cytomegalovirus infection in renal transplant recipients.

J. Manischewitz, A. Rook, G. Quinnan,, 1984, The American journal of medicine.

Cytotoxic t cells in cytomegalovirus infection: HLA-restricted T-lymphocyte and non-T-lymphocyte cytotoxic responses correlate with recovery from cytomegalovirus infection in bone-marrow-transplant recipients.

J. Manischewitz, A. Rook, G. Moreschi, 1982, The New England journal of medicine.

HLA-restricted cytotoxic T lymphocytes are an early immune response and important defense mechanism in cytomegalovirus infections.

J. Manischewitz, A. Rook, G. Quinnan,, 1984, Reviews of infectious diseases.

The role of natural killer cells and antibody-dependent cell-mediated cytotoxicity during murine cytomegalovirus infection

G. Quinnan,, J. Manischewitz, 1979, The Journal of experimental medicine.

Influenza vaccines in children. Comparison of new cetrimonium bromide and standard ether-treated vaccines.

C. Denning, P. Gross, P. Gaerlan, 1983, American journal of diseases of children.

Genetically determined resistance to lethal murine cytomegalovirus infection is mediated by interferon-dependent and -independent restriction of virus replication

J. Manischewitz, G. Quinnan,, 1987, Journal of virology.

Interferon-induced 2'-5' oligoadenylate synthetase during interferon-alpha therapy in homosexual men with Kaposi's sarcoma: marked deficiency in biochemical response to interferon in patients with acquired immunodeficiency syndrome.

D. Longo, E. Gelmann, R. Silverman, 1985, The Journal of infectious diseases.

ANTI-RETROVIRAL EFFECTS OF INTERFERON-α IN AIDS-ASSOCIATED KAPOSI'S SARCOMA

M. Baseler, A. Fauci, J. Kovacs, 1988, The Lancet.

A phase I trial of recombinant human interferon-γ in patients with Kaposi's sarcoma and the acquired immunodeficiency syndrome (AIDS)

R. Davey, A. Fauci, H. Masur, 1989, Journal of Clinical Immunology.

Interleukin 2 enhances the natural killer cell activity of acquired immunodeficiency syndrome patients through a gamma-interferon-independent mechanism.

A. Fauci, H. Masur, H. Lane, 1985, Journal of immunology.

Lack of evidence for HIV-2 infection among at-risk individuals in Brazil.

D. E. Parks, R. M. Hendry, G. Quinnan,, 1991, Journal of acquired immune deficiency syndromes.

A Novel Human Antibody against Human Immunodeficiency Virus Type 1 gp120 Is V1, V2, and V3 Loop Dependent and Helps Delimit the Epitope of the Broadly Neutralizing Antibody Immunoglobulin G1 b12

Paul W. H. I. Parren, Dennis R. Burton, D. Burton, 2003, Journal of Virology.

Interleukin 2 therapy in infectious diseases: Rationale and prospects

J. Djeu, J. Siegel, G. Quinnan,, 1984, Infection.

Interleukin 2 therapy in infectious diseases: Rationale and prospects

J. Djeu, J. Siegel, G. Quinnan,, 1984, Infection.

Selective defects in cytomegalovirus- and mitogen-induced lymphocyte proliferation and interferon release in patients with acquired immunodeficiency syndrome.

H. Masur, J. Djeu, J. Manischewitz, 1985, The Journal of infectious diseases.

Relation of chronic disease and immune response to influenza vaccine in the elderly.

R. Douglas, P. Gross, M. Weksler, 1989, Vaccine.

Pharmacokinetics of lymphocyte-derived and recombinant DNA-derived interleukin-2 after intravenous administration to patients with the acquired immunodeficiency syndrome.

A. Fauci, H. Lane, J. Siegel, 1985, Journal of biological response modifiers.

Variable infections with and serologic responses of rabbits to five different HIV-1 strains, including one neural tissue isolate.

L. Sawyer, I. Hewlett, P. Snoy, 1992, Microbios.

Conducting clinical trials in sub-Saharan Africa: challenges and lessons learned from the Malawi Cryptosporidium study

L. Sawyer, R. Lindblad, W. V. Van Voorhis, 2020, Trials.

USE OF POLYMERASE CHAIN REACTION TECHNIQUE TO CONFIRM VECTEST@ SCREENING RESULTS IN PI^A,SMODIUM FALCIPARUM AND'^'y3,"'1",!;:;{#;,87."1'.fffi336ffi%tTINFECTED

G. Quinnan,, D. SANTOS-CIMINERA, Nicole L. Ache, 2004 .

High Endemicity of Human T-Cell Lymphotropic Virus Type 1 Among Pregnant Women in Peru

K. Holmes, J. Zunt, S. Montano, 2006, Journal of Acquired Immune Deficiency Syndromes.

H. Masur, R. Friedman, A. Rook, 1984, American journal of clinical pathology.

Inactivation of human T‐cell lymphotropic virus, type III by heat, chemicals, and irradiation

R. Purcell, J. Epstein, A. Wittek, 1986, Transfusion.

Clinical outcomes of elite controllers, viremic controllers, and long-term nonprogressors in the US Department of Defense HIV natural history study.

B. Agan, A. Weintrob, A. Ganesan, 2009, The Journal of infectious diseases.

Protection of Rhesus Monkeys against Infection with Minimally Pathogenic Simian-Human Immunodeficiency Virus: Correlations with Neutralizing Antibodies and Cytotoxic T Cells

C. Broder, D. Montefiori, G. Sutter, 2005, Journal of Virology.

Cross-reactive HIV-1 neutralizing monoclonal antibodies selected by screening of an immune human phage library against an envelope glycoprotein (gp140) isolated from a patient (R2) with broadly HIV-1 neutralizing antibodies.

S. Rybak, C. Broder, J. Louis, 2007, Virology.

Effects of interferon-alpha in patients with AIDS-associated Kaposi's sarcoma are related to blood interferon levels and dose.

L. Sawyer, J. Metcalf, J. Kovacs, 1990, Cytokine.

Sera from patients with the acquired immunodeficiency syndrome inhibit production of interleukin-2 by normal lymphocytes.

E. Gelmann, H. Masur, J. Djeu, 1985, The Journal of clinical investigation.

Cytomegalovirus-specific Cytotoxic Activities of Lymphocytes from Patients with the Acquired Immune Deficiency Syndrome

A. Fauci, H. Masur, J. Djeu, 1983 .

Relative importance of viruses and bacteria in the etiology of pediatric diarrhea in Taiwan.

H. Dupont, J. Olson, P. Echeverria, 1977, The Journal of infectious diseases.

PREVALENCE, CLINICAL MANIFESTATIONS, AND IMMUNOLOGY OF HERPESVIRUS INFECTIONS IN THE ACQUIRED IMMUNODEFICIENCY SYNDROME

H. Masur, J. Djeu, J. Manischewitz, 1984, Annals of the New York Academy of Sciences.

A Variable Region 3 (V3) Mutation Determines a Global Neutralization Phenotype and CD4-Independent Infectivity of a Human Immunodeficiency Virus Type 1 Envelope Associated with a Broadly Cross-Reactive, Primary Virus-Neutralizing Antibody Response

Susan Zolla-Pazner, Peter Bouma, J. Margolick, 2002, Journal of Virology.

Reactivity of an HIV gag gene polypeptide expressed in E. coli with sera from AIDS patients and monoclonal antibodies to gag.

G. Quinnan,, A. Woerner, C. Marcus-Sekura, 1988, Biochimica et biophysica acta.

International collaborative study to compare assays for antibodies that neutralize human immunodeficiency virus.

D. Katzenstein, G. Quinnan,, L. Vujcic, 1990, AIDS research and human retroviruses.

Human immunodeficiency virus neutralizing antibodies in sera from North Americans and Africans.

D. Katzenstein, T. Quinn, S. Rastogi, 1990, Journal of acquired immune deficiency syndromes.

Risks and benefits of vaccinia-vectored vaccine use from the regulatory perspective

G. Quinnan,, C. Marcus-Sekura, 1989 .

Identiﬁcation and Characterization of a New Cross-Reactive Human Immunodeﬁciency Virus Type 1-Neutralizing Human Monoclonal Antibody

Dennis R. Burton, Xiaodong Xiao, Peter Bouma, 2022 .

Partial immune reconstitution in a patient with the acquired immunodeficiency syndrome.

D. Longo, H. Masur, H. Lane, 1984, New England Journal of Medicine.

Comparison of the Raji cell line fluorescent antibody to membrane antigen test and the enzyme-linked immunosorbent assay for determination of immunity to varicella-zoster virus

P. Gerber, G. Quinnan,, L. Vujcic, 1982, Journal of clinical microbiology.

Human class I MHC-restricted cytotoxic T-lymphocytes specific for human immunodeficiency virus envelope antigens.

D. Shepp, G. Quinnan,, D. Mann, 1988, AIDS.

Allogeneic bone marrow transplantation, zidovudine, and human immunodeficiency virus type 1 (HIV-1) infection. Studies in a patient with non-Hodgkin lymphoma.

H. Farzadegan, J. Rossi, A. Donnenberg, 1989, Annals of internal medicine.

Influenza vaccine and pneumonia mortality in a nursing home population.

J. L. Montagne, W. Blackwelder, R. Kaslow, 1986, Archives of internal medicine.

Cytotoxic T cells specific for cytomegalovirus : a potential therapy for immunocompromised patients. Discussion

Greenberg, S. Riddell, P. Greenberg, 1991 .

ANTIBODIES TO SIMIAN IMMUNODEFICIENCY VIRUS IN AFRICAN GREEN MONKEYS IN AFRICA IN 1957-62

R. M. Hendry, J. Epstein, G. Quinnan,, 1986, The Lancet.

Five-year follow-up study of recipients of live varicella vaccine using enhanced neutralization and fluorescent antibody membrane antigen assays.

G. Quinnan,, L. Vujcic, Y. Asano, 1983, Pediatrics.

Public Health Service study of Reye's syndrome and medications. Report of the main study.

P. Pinsky, R. Kaslow, L. Schonberger, 1987, JAMA.

Induction of Primary Virus-Cross-Reactive Human Immunodeficiency Virus Type 1-Neutralizing Antibodies in Small Animals by Using an Alphavirus-Derived In Vivo Expression System

C. Broder, Y. Shao, V. Polonis, 2003, Journal of Virology.

Summary of clinical trials of inactivated influenza vaccine - 1978.

J. L. Montagne, F. Ennis, W. Blackwelder, 1983, Reviews of infectious diseases.

AIDS, blood transfusions, and directed donations.

A. Wittek, G. Quinnan,, M. Phelan, 1986 .

Extensively cross-reactive anti-HIV-1 neutralizing antibodies induced by gp140 immunization

C. Broder, Y. Shao, N. Mathy, 2007, Proceedings of the National Academy of Sciences.

More on partitioning and inactivation of AIDS virus in immune globulin preparations.

A. Wittek, J. Epstein, G. Quinnan,, 1986, The New England journal of medicine.

Concordant Modulation of Neutralization Resistance and High Infectivity of the Primary Human Immunodeficiency Virus Type 1 MN Strain and Definition of a Potential gp41 Binding Site in gp120

Igor A. Sidorov, D. Dimitrov, I. Sidorov, 2003, Journal of Virology.

Primary Virus Envelope Cross-Reactivity of the Broadening Neutralizing Antibody Response during Early Chronic Human Immunodeficiency Virus Type 1 Infection

J. Margolick, G. Quinnan,, Xi Chen, 1999, Journal of Virology.

Antibody-dependent cellular cytotoxicity specific for the envelope antigens of human immunodeficiency virus.

B. Moss, S. Chakrabarti, D. Shepp, 1988, The Journal of infectious diseases.

Deficient, HLA-restricted, cytomegalovirus-specific cytotoxic T cells and natural killer cells in patients with the acquired immunodeficiency syndrome.

E. Gelmann, H. Masur, J. Manischewitz, 1985, The Journal of infectious diseases.

Role of cytotoxic T lymphocytes in murine cytomegalovirus infection.

G. Quinnan,, P. Ennis, J. Manischewitz, 1980, The Journal of general virology.

Cross-Reactive Human IgM-Derived Monoclonal Antibodies that Bind to HIV-1 Envelope Glycoproteins

H. Liao, B. Haynes, C. Broder, 2010, Viruses.

Cross-Reactive Human Immunodeficiency Virus Type 1-Neutralizing Human Monoclonal Antibody That Recognizes a Novel Conformational Epitope on gp41 and Lacks Reactivity against Self-Antigens

B. Haynes, M. Humbert, C. Broder, 2008, Journal of Virology.

Immunization of Rabbits with Highly Purified, Soluble, Trimeric Human Immunodeficiency Virus Type 1 Envelope Glycoprotein Induces a Vigorous B Cell Response and Broadly Cross-Reactive Neutralization

C. Broder, D. Montefiori, Min Lu, 2014, PloS one.

Detection of human immunodeficiency virus core protein in plasma by enzyme immunoassay. Association of antigenemia with symptomatic disease and T-helper cell depletion.

H. Lane, J. Epstein, A. Wittek, 1987, Annals of internal medicine.

Both Neutralization Resistance and High Infectivity Phenotypes Are Caused by Mutations of Interacting Residues in the Human Immunodeficiency Virus Type 1 gp41 Leucine Zipper and the gp120 Receptor- and Coreceptor-Binding Domains

G. Quinnan,, E. Park, 1999, Journal of Virology.

A Global Neutralization Resistance Phenotype of Human Immunodeficiency Virus Type 1 Is Determined by Distinct Mechanisms Mediating Enhanced Infectivity and Conformational Change of the Envelope Complex

Susan Zolla-Pazner, S. Zolla-Pazner, G. Quinnan,, 2000, Journal of Virology.

Neutralization and infectivity characteristics of envelope glycoproteins from human immunodeficiency virus type 1 infected donors whose sera exhibit broadly cross-reactive neutralizing activity.

H. Katinger, James E. Robinson, L. Heyndrickx, 2006, Virology.

Preparation and characterization of human HIV type 1 neutralizing reference sera.

G. Quinnan,, L. Vujcic, 1995, AIDS research and human retroviruses.

Molecular epidemiology of Plasmodium vivax in the State of Amazonas, Brazil.

D. Roberts, G. Quinnan,, Patricia D. Santos-Ciminera, 2007, Acta tropica.

Multiple Interactions across the Surface of the gp120 Core Structure Determine the Global Neutralization Resistance Phenotype of Human Immunodeficiency Virus Type 1

D. Dimitrov, I. Sidorov, G. Quinnan,, 2003, Journal of Virology.

Probing the HIV gp120 Envelope Glycoprotein Conformation by NMR*

C. Broder, Lijun Rong, M. Caffrey, 2011, The Journal of Biological Chemistry.

Malaria Diagnosis and Hospitalization Trends, Brazil

D. Roberts, G. Quinnan,, Patricia D. Santos-Ciminera, 2007, Emerging infectious diseases.

Efficacy of inactivated influenza vaccine delivered by oral administration.

G. Quinnan,, K. S. Chen, 1989, Current topics in microbiology and immunology.

Neutralizing Antibody Responses in Macaques Induced by Human Immunodeficiency Virus Type 1 Monovalent or Trivalent Envelope Glycoproteins

C. Broder, Hong D. Chen, G. Quinnan,, 2013, PloS one.

Broadly cross-reactive HIV neutralizing human monoclonal antibody Fab selected by sequential antigen panning of a phage display library.

S. Rybak, C. Broder, D. Dimitrov, 2003, Journal of immunological methods.

From the National Institute of Allergy and Infectious Diseases Report of a Workshop on Respiratory Syncytial Virus and Parainfluenza Viruses

J. L. Montagne, W. S. Jordan, E. Walsh, 1983 .

Tropical medicine training in the Department of Defense.

D. Brett-Major, R. Coldren, P. Weina, 2012, Military medicine.

Probing the HIV gp120 Envelope Glycoprotein Conformation by NMR*

C. Broder, Lijun Rong, M. Caffrey, 2011, The Journal of Biological Chemistry.

Virus-specific cytotoxic lymphocyte responses are predictive of the outcome of cytomegalovirus infection of renal transplant recipients.

J. Manischewitz, J. Burdick, J. Siegel, 1984, Transplantation proceedings.

Comparative antigenicity and immunogenicity of A/USSR/77 influenza vaccines in normal and primed mice.

F. Ennis, C. Mclaren, G. Quinnan,, 1980, Infection and immunity.